Democratizing hedge fund level analysis tools for everyone
| Name | Royal Prima Tbk. |
| Sector | Healthcare |
| Industry | Healthcare Equipment & Providers |
| Code | F1 |
| Latest Quarterly | 06-30-25 |
| Name | Latest % | A Month Ago % |
|---|---|---|
| Dr. I Nyoman Ehrich Lister | 71.72 | 71.72 |
| Public < 5% | 21.55 | 21.55 |
| Robin | 6.25 | 6.25 |
| Treasury Shares | 0.45 | 0.45 |
| Mok Siu Pen | 0.03 | 0.03 |
| Source | 2022 | 2021 |
|---|---|---|
| PRIM | F1 | RSU Royal Prima |
| PRIM | F1 | Rumah Sakit Marelan |
| PRIM | F1 | RS Royal Prima Jambi |
| PRIM | F1 | Others |
| PRIM | F1 | In-patient |
| PRIM | F1 | Out-patient |
| Region | 2022 | 2021 |
|---|---|---|
| PRIM | F1 | Indonesia |
| PRIM | F1 | Others |
| Valuation | Ratio | Rank |
|---|---|---|
| P/S | 0.83 | # 3 / 22 |
| EV_EBITDA | 10.84 | # 5 / 22 |
| PER | -30.94 | --- / 22 |
| PBV | 0.29 | # 2 / 22 |
| DER | 0.12 | # 1 / 22 |
| Profitability | Ratio | Rank |
|---|---|---|
| NPM % | -2.701 | --- / 22 |
| ROA % | -0.8500000000000001 | --- / 22 |
| ROE % | -0.95 | --- / 22 |
| Year | DPS | Yield [%] |
|---|
| Timeframe | Performance |
|---|---|
| 1W % | -1.2 |
| 1Mo % | -6.8 |
| 3Mo % | -9.9 |
| 1Yr % | 34.4 |
| Stocks | PER | Market Cap | EV | Revenue | EBITDA | Net Profit |
|---|---|---|---|---|---|---|
| SRAJ | -1,706.31 | 201.94 T | 206.18 T | 2,500 B | 479 B | -118 B |
| MIKA | 25.12 | 34.07 T | 33.23 T | 5,307 B | 2,049 B | 1,356 B |
| SILO | 32.15 | 32.65 T | 36.15 T | 12,567 B | 2,702 B | 1,015 B |
| CARE | 8,388.89 | 25.10 T | 25.56 T | 314 B | 67 B | 3 B |
| HEAL | 44.60 | 21.13 T | 24.85 T | 7,051 B | 1,874 B | 475 B |
| PRAY | 53.05 | 11.52 T | 13.07 T | 2,332 B | 510 B | 218 B |